IL10 and triple-A syndrome: A total of 8 studies were included, and nostatistically significant increase or decrease in circulating IL-10 levels wereobserved between AAA patients in comparison with controls (SMD = –0.01, 95% CI:–0.09–0.06, I2 = 30.9%, p = 0.710, Fig. 5A).